{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:27:06Z","timestamp":1793327226268,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.tem.2023.01.001","type":"journal-article","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T01:41:11Z","timestamp":1674870071000},"page":"135-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["mTORC1 syndrome (TorS): unified paradigm for diabetes\/metabolic syndrome"],"prefix":"10.1016","volume":"34","author":[{"given":"Jacob","family":"Bar-Tana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2023.01.001_bb0005","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2337\/dc22-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2023.01.001_bb0010","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.tem.2023.01.001_bb0015","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2023.01.001_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2023.01.001_bb0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00125-021-05592-3","article-title":"Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies","volume":"65","author":"Schlesinger","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2023.01.001_bb0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11886-011-0238-6","article-title":"Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT","volume":"14","author":"Terry","year":"2012","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.tem.2023.01.001_bb0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-8587(20)30369-7","article-title":"Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial","volume":"9","author":"Wheeler","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.tem.2023.01.001_bb0040","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3390\/jcm11071904","article-title":"The impact of novel anti-diabetic medications on CV outcomes: a new therapeutic horizon for diabetic and non-diabetic cardiac patients","volume":"11","author":"Mazin","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tem.2023.01.001_bb0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2023.01.001_bb0050","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12916-018-1225-1","article-title":"Insulin translates unfavourable lifestyle into obesity","volume":"16","author":"Kolb","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.tem.2023.01.001_bb0055","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2023.01.001_bb0060","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2147\/DMSO.S250699","article-title":"Anti-lipolysis induced by insulin in diverse pathophysiologic conditions of adipose tissue","volume":"13","author":"Zhao","year":"2020","journal-title":"Diab. Metab. Syndr. Obes."},{"key":"10.1016\/j.tem.2023.01.001_bb0065","first-page":"671","article-title":"Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited","volume":"36","author":"da Silva","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.tem.2023.01.001_bb0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-020-0295-5","article-title":"Hyperinsulinaemia in cancer","volume":"20","author":"Gallagher","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tem.2023.01.001_bb0075","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.pcad.2017.09.001","article-title":"Insulin therapy increases cardiovascular risk in type 2 diabetes","volume":"60","author":"Herman","year":"2017","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.tem.2023.01.001_bb0080","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/ejhf.1146","article-title":"Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes","volume":"20","author":"Cosmi","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.tem.2023.01.001_bb0085","first-page":"1","article-title":"Serine phosphorylation by mTORC1 promotes IRS-1 degradation through SCF\u03b2-TRCP E3 ubiquitin ligase","volume":"5","author":"Yoneyama","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.tem.2023.01.001_bb0090","doi-asserted-by":"crossref","first-page":"E173","DOI":"10.1152\/ajpendo.00025.2019","article-title":"Role of Grb10 in mTORC1-dependent regulation of insulin signaling and action in human skeletal muscle cells","volume":"318","author":"Edick","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.01.001_bb0095","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/MCB.00601-09","article-title":"mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling","volume":"30","author":"Julien","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tem.2023.01.001_bb0100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature02866","article-title":"Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity","volume":"431","author":"Um","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.tem.2023.01.001_bb0105","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.4161\/cc.20036","article-title":"mTORC1 signaling and regulation of pancreatic \u03b2-cell mass","volume":"11","author":"Blandino-Rosano","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tem.2023.01.001_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.741114","article-title":"Insulin resistance, secretion and clearance -taming the three effector encounter of type 2 diabetes","volume":"12","author":"Bar-Tana","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2023.01.001_bb0115","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.2337\/db13-0970","article-title":"Pancreatic \u03b2-cell failure mediated by mTORC1 hyperactivity and autophagic impairment","volume":"63","author":"Bartolom\u00e9","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2023.01.001_bb0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cmet.2017.11.004","article-title":"mTORC1 signaling: a double-edged sword in diabetic \u03b2 cells","volume":"27","author":"Ardestani","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2023.01.001_bb0125","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3390\/ijms23031153","article-title":"Modulating mTOR signaling as a promising therapeutic strategy for atherosclerosis","volume":"23","author":"Poznyak","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2023.01.001_bb0130","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2023.01.001_bb0135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","article-title":"New insights into the role of mTOR signaling in the cardiovascular system","volume":"122","author":"Sciarretta","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2023.01.001_bb0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/antiox10020321","article-title":"Roles of mTOR in diabetic kidney disease","volume":"10","author":"Yamahara","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.tem.2023.01.001_bb0145","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41581-020-0309-2","article-title":"Autophagy in kidney homeostasis and disease","volume":"16","author":"Tang","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.tem.2023.01.001_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107954","article-title":"Proximal tubule mTORC1 is a central player in the pathophysiology of diabetic nephropathy and its correction by SGLT2 inhibitors","volume":"32","author":"Kogot-Levin","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2023.01.001_bb0155","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12886-020-01553-3","article-title":"The expression and significance of mTORC1 in diabetic retinopathy","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.tem.2023.01.001_bb0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ynpai.2018.03.002","article-title":"Revealing brain mechanisms of mTOR-mediated translational regulation: Implications for chronic pain","volume":"4","author":"Cho","year":"2018","journal-title":"Neurobiol. Pain"},{"key":"10.1016\/j.tem.2023.01.001_bb0165","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tem.2023.01.001_bb0170","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/embor.2013.5","article-title":"The multifaceted role of mTORC1 in the control of lipid metabolism","volume":"14","author":"Ricoult","year":"2013","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tem.2023.01.001_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.livres.2020.02.004","article-title":"Nutrient mTORC1 signaling contributes to hepatic lipid metabolism in the pathogenesis of non-alcoholic fatty liver disease","volume":"4","author":"Chen","year":"2020","journal-title":"Liver Res."},{"key":"10.1016\/j.tem.2023.01.001_bb0180","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00125-015-3525-8","article-title":"Pathophysiology of diabetic dyslipidaemia: where are we?","volume":"58","author":"Verg\u00e8s","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2023.01.001_bb0185","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/HYPERTENSIONAHA.120.14708","article-title":"mTORC1 (mechanistic target of rapamycin complex 1) signaling in endothelial and smooth muscle cells is required for vascular function","volume":"77","author":"Reho","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2023.01.001_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109442","article-title":"Novel compounds for the modulation of mTOR and autophagy to treat neurodegenerative diseases","volume":"65","author":"Heras-Sandoval","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.tem.2023.01.001_bb0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","article-title":"mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges","volume":"10","author":"Zou","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.tem.2023.01.001_bb0200","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.17196.1","article-title":"mTOR as a central regulator of lifespan and aging","volume":"8","author":"Papadopoli","year":"2019","journal-title":"F1000Res."},{"key":"10.1016\/j.tem.2023.01.001_bb0205","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cmet.2016.12.009","article-title":"Metformin inhibits hepatic mTORC1 signaling via dose-dependent mechanisms involving AMPK and the TSC complex","volume":"25","author":"Howell","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2023.01.001_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172695","article-title":"Pioglitazone protects tubular cells against hypoxia\/reoxygenation injury through enhancing autophagy via AMPK-mTOR signaling pathway","volume":"863","author":"Xi","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tem.2023.01.001_bb0215","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cmet.2020.06.020","article-title":"SGLT2 inhibition mediates protection from diabetic kidney disease by promoting ketone body-induced mTORC1 inhibition","volume":"32","author":"Tomita","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2023.01.001_bb0220","doi-asserted-by":"crossref","first-page":"E1019","DOI":"10.1152\/ajpendo.00195.2019","article-title":"Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway","volume":"319","author":"Yang","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.01.001_bb0225","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s40265-021-01510-4","article-title":"Targeting AMPK by statins: a potential therapeutic approach","volume":"81","author":"Dehnavi","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.tem.2023.01.001_bb0230","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1158\/0008-5472.CAN-16-2400","article-title":"Aspirin suppresses growth in PI3K-mutant breast cancer by activating AMPK and inhibiting mTORC1 signaling","volume":"77","author":"Henry","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.tem.2023.01.001_bb0235","doi-asserted-by":"crossref","first-page":"H1232","DOI":"10.1152\/ajpheart.00040.2004","article-title":"ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells","volume":"287","author":"Hafizi","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tem.2023.01.001_bb0240","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5483\/BMBRep.2019.52.1.299","article-title":"Growth signaling and longevity in mouse models","volume":"52","author":"Kim","year":"2019","journal-title":"BMB Rep."},{"key":"10.1016\/j.tem.2023.01.001_bb0245","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/dom.12412","article-title":"Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer","volume":"17","author":"Holden","year":"2015","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tem.2023.01.001_bb0250","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ando.2017.08.001","article-title":"A severe but reversible reduction in insulin sensitivity is observed in patients with insulinoma","volume":"79","author":"Furnica","year":"2018","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.tem.2023.01.001_bb0255","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.tem.2023.01.001_bb0260","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1741-7007-11-88","article-title":"Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain","volume":"11","author":"Garc\u00eda-Ruiz","year":"2013","journal-title":"BMC Biol."},{"key":"10.1016\/j.tem.2023.01.001_bb0265","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.molmet.2016.08.014","article-title":"The diabetes medication canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration","volume":"5","author":"Villani","year":"2016","journal-title":"Mol. Metab."},{"key":"10.1016\/j.tem.2023.01.001_bb0270","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jcsm.12654","article-title":"Effects of statins on mitochondrial pathways","volume":"12","author":"Mollazadeh","year":"2021","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.tem.2023.01.001_bb0275","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2011.06.016","article-title":"Acetylsalicylic acid-induced oxidative stress, cell cycle arrest, apoptosis and mitochondrial dysfunction in human hepatoma HepG2 cells","volume":"668","author":"Raza","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tem.2023.01.001_bb0280","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/jcmm.13432","article-title":"Inhibition of mitochondrial complex I improves glucose metabolism independently of AMPK activation","volume":"22","author":"Hou","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tem.2023.01.001_bb0285","doi-asserted-by":"crossref","first-page":"12250","DOI":"10.1074\/jbc.RA119.008488","article-title":"Inhibition of mitochondrial complex 1 by the S6K1 inhibitor PF-4708671 partly contributes to its glucose metabolic effects in muscle and liver cells","volume":"294","author":"Shum","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2023.01.001_bb0290","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bcp.2008.08.028","article-title":"AMPK activation by long chain fatty acyl analogs","volume":"76","author":"Za\u2019tara","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tem.2023.01.001_bb0295","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40170-020-00223-8","article-title":"Treatment of ErbB2 breast cancer by mitochondrial targeting","volume":"8","author":"Eldad","year":"2020","journal-title":"Cancer Metab."},{"key":"10.1016\/j.tem.2023.01.001_bb0300","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/acel.12186","article-title":"The co-occurrence of mtDNA mutations on different oxidative phosphorylation subunits, not detected by haplogroup analysis, affects human longevity and is population specific","volume":"13","author":"Raule","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.tem.2023.01.001_bb0305","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tem.2023.01.001_bb0310","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","article-title":"Metabolic messengers: tumour necrosis factor","volume":"3","author":"Sethi","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.tem.2023.01.001_bb0315","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.jmb.2019.09.016","article-title":"Recent insights into mechanisms of \u03b2-cell lipo- and glucolipotoxicity in type 2 diabetes","volume":"432","author":"Lytrivi","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tem.2023.01.001_bb0320","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3390\/metabo10110444","article-title":"Developmental programming and glucolipotoxicity: insights on beta cell inflammation and diabetes","volume":"10","author":"Cerf","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.tem.2023.01.001_bb0325","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2337\/db19-0138","article-title":"Glucolipotoxicity, \u03b2-cells, and diabetes: the emperor has no clothes","volume":"69","author":"Weir","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2023.01.001_bb0330","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.115.306825","article-title":"Epidemiology of obesity and diabetes and their cardiovascular complications","volume":"118","author":"Bhupathiraju","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2023.01.001_bb0335","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40265-013-0023-5","article-title":"Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management","volume":"73","author":"Chehade","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.tem.2023.01.001_bb0340","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/jch.12638","article-title":"Diabetes and hypertension: a comparative review of current guidelines","volume":"18","author":"Cryer","year":"2016","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.tem.2023.01.001_bb0345","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.tem.2023.01.001_bb0350","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cegh.2020.05.016","article-title":"Diabetic kidney disease: an overview of prevalence, risk factors, and biomarkers","volume":"9","author":"Hussain","year":"2021","journal-title":"Clin. Epidemiol. Glob. Health"},{"key":"10.1016\/j.tem.2023.01.001_bb0355","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/dme.12119","article-title":"Prevalence of diabetic retinopathy in type 2 diabetes in developing and developed countries","volume":"30","author":"Ruta","year":"2013","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2023.01.001_bb0360","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7898.1","article-title":"Updates in diabetic peripheral neuropathy","volume":"5","author":"Juster-Switlyk","year":"2016","journal-title":"F1000Res."},{"key":"10.1016\/j.tem.2023.01.001_bb0365","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.tem.2023.01.001_bb0370","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3389\/fgene.2018.00657","article-title":"Exposing the causal effect of C-reactive protein on the risk of type 2 diabetes mellitus: a Mendelian randomization study","volume":"9","author":"Cheng","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.tem.2023.01.001_bb0375","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fnins.2018.00383","article-title":"Alzheimer\u2019s disease and type 2 diabetes: a critical assessment of the shared pathological traits","volume":"12","author":"Chatterjee","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tem.2023.01.001_bb0380","article-title":"Prevalence of polycystic ovary syndrome in patients with pediatric type 2 diabetes: a systematic review and meta-analysis","volume":"5","author":"Cioana","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tem.2023.01.001_bb0385","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40257-021-00590-y","article-title":"Psoriasis in patients with metabolic syndrome or type 2 diabetes mellitus: treatment challenges","volume":"22","author":"Pannu","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.tem.2023.01.001_bb0390","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.2337\/dc20-0204","article-title":"Association of type 2 diabetes with cancer: a meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people","volume":"43","author":"Ling","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2023.01.001_bb0395","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tem.2023.01.001_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.655731","article-title":"The mTOR-autophagy axis and the control of metabolism","volume":"9","author":"Deleyto-Seldas","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tem.2023.01.001_bb0405","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00441-17","article-title":"MTORC1 regulates both general autophagy and mitophagy induction after oxidative phosphorylation uncoupling","volume":"37","author":"Bartolom\u00e9","year":"2017","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tem.2023.01.001_bb0410","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/2211-5463.13347","article-title":"The mTOR-lysosome axis at the centre of ageing","volume":"12","author":"Carosi","year":"2022","journal-title":"FEBS Open Bio."},{"key":"10.1016\/j.tem.2023.01.001_bb0415","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1038\/ncomms10662","article-title":"Lysosomal recruitment of TSC2 is a universal response to cellular stress","volume":"7","author":"Demetriades","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2023.01.001_bb0420","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cmet.2019.01.018","article-title":"Caloric restriction mimetics against age-associated disease: targets, mechanisms, and therapeutic potential","volume":"29","author":"Madeo","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2023.01.001_bb0425","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41580-021-00411-4","article-title":"Molecular mechanisms of dietary restriction promoting health and longevity","volume":"23","author":"Green","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tem.2023.01.001_bb0430","doi-asserted-by":"crossref","first-page":"4326549","DOI":"10.1155\/2020\/4326549","article-title":"Roux-en-Y gastric bypass in obese diabetic rats promotes autophagy to improve lipid metabolism through mTOR\/p70S6K signaling pathway","volume":"2020","author":"Ma","year":"2020","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.tem.2023.01.001_bb0435","doi-asserted-by":"crossref","first-page":"E737","DOI":"10.1152\/ajpendo.00120.2017","article-title":"REDD1 induction regulates the skeletal muscle gene expression signature following acute aerobic exercise","volume":"313","author":"Gordon","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.01.001_bb0440","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1038\/s41598-020-65397-z","article-title":"Enhanced skeletal muscle insulin sensitivity after acute resistance-type exercise is upregulated by rapamycin-sensitive mTOR complex 1 inhibition","volume":"10","author":"Kido","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2023.01.001_bb0445","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1249\/MSS.0000000000002591","article-title":"Exercise reduces medication for metabolic syndrome management: a 5-year follow-up study","volume":"53","author":"Morales-Palomo","year":"2021","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.tem.2023.01.001_bb0450","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cmet.2017.10.009","article-title":"AMPK: sensing glucose as well as cellular energy status","volume":"27","author":"Lin","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2023.01.001_bb0455","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41420-020-0260-9","article-title":"How does mTOR sense glucose starvation? AMPK is the usual suspect","volume":"6","author":"Leprivier","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.tem.2023.01.001_bb0460","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/17446651.2018.1523713","article-title":"Implementing a low-carbohydrate, ketogenic diet to manage type 2 diabetes mellitus","volume":"13","author":"Westman","year":"2018","journal-title":"Expert. Rev. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.01.001_bb0465","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3390\/nu13041302","article-title":"Effects of calorie restriction on health span and insulin resistance: classic calorie restriction diet vs. ketosis-inducing diet","volume":"13","author":"Napole\u00e3o","year":"2021","journal-title":"Nutrients"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276023000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276023000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:44:09Z","timestamp":1760906649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276023000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1043276023000127"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2023.01.001","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mTORC1 syndrome (TorS): unified paradigm for diabetes\/metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2023.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}